Spotlight: Pitt team redesigns an epilepsy drug

spotlight

A Pitt team has redesigned the structural components of an existing epilepsy drug--retigabine--in order to make it a more potent, targeted therapy. The older drug activated all 5 types of potassium transport channels in the KCNQ category, but only two were necessary for stabilizing the membranes of brain cells. And the same approach could also work against tinnitus. Release

> Scientists at the University of Edinburgh have identified a gene linked to craving salt, pointing a way to better for controlling blood pressure. And they say that an existing medication could be used to do that work. Release

> A Scripps team has been exploring the potential of a plant virus as a drug delivery tool. Release